Gullain Barre Syndrome: Acute Motor Axonal Neuropathy
DOI:
https://doi.org/10.63682/jns.v14i29S.6777Keywords:
Gullian barre syndrome, Axoglial junction, Plasmapheresis, Neuro rehabilitationAbstract
BACKGROUND
Guillain-Barré Syndrome (GBS) is an acute immune-mediated polyneuropathy that results in ascending paralysis, autonomic dysfunction, and neuromuscular impairment.
OBJECTIVES
This case highlights the presentation, diagnosis, and therapeutic management of Acute Motor Axonal Neuropathy (AMAN), a severe GBS variant.
MATERIAL AND METHODS:
A 73-year-old male patient case report, Cerebrospinal fluid (CSF) analysis showed mild pleocytosis with albuminocytologic dissociation, and MRI findings revealed an incidental posterior fossa arachnoid cyst.
RESULT
A 73-year-old male presented with gait ataxia, progressive limb weakness, and numbness. Cerebrospinal fluid (CSF) analysis showed mild pleocytosis with albuminocytologic dissociation, and MRI findings revealed an incidental posterior fossa arachnoid cyst. The patient underwent plasmapheresis (five cycles) along with neuro-rehabilitative therapy to remove pathogenic circulating autoantibodies and enhance recovery. Following plasmapheresis and physiotherapy, the patient demonstrated substantial neurological improvement, with restored motor function, preserved bulbar reflexes, and safe oral intake.
CONCLUSION
The critical role of early immunomodulatory intervention, particularly plasmapheresis and rehabilitation, in managing GBS variants like AMAN. Multidisciplinary care, close outpatient monitoring, and structured rehabilitative support are essential in optimizing functional outcomes and minimizing recurrence risks.
Downloads
Metrics
References
Bragazzi NL, Kolahi AA, Nejadghaderi SA, Lochner P, Brigo F, Naldi A, et al. Global, regional, and national burden of Guillain–Barré syndrome and its underlying causes from 1990 to 2019. Journal of Neuroinflammation [Internet]. 2021 Nov 11;18(1).Available from: https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-021-02319-4
Xu L, Zhao C, Bao Y, Liu Y, Liang Y, Wei J, et al. Variation in worldwide incidence of Guillain-Barré syndrome: a population-based study in urban China and existing global evidence. Frontiers in Immunology. 2024 Sep 10;15.
Kumar R, Co-Authors S, Suthar R. Indian Academy of Pediatrics (IAP) Under the Auspices of the IAP Action Plan 2022 Upendra Kinjawadekar Guillain-Barré Syndrome [Internet]. Available from: https://iapindia.org/pdf/Ch-053-stg-guillain-barre-syndrome.pdf
What are the types of Guillain-Barre syndrome? [Internet]. www.medicalnewstoday.com. 2024. Available from: https://www.medicalnewstoday.com/articles/types-of-guillain-barre-syndrome
Mayo Clinic. Guillain-Barre syndrome - Symptoms and causes [Internet]. Mayo Clinic. 2024. Available from: https://www.mayoclinic.org/diseases-conditions/guillain-barre-syndrome/symptoms-causes/syc-20362793
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet (London, England) [Internet]. 2016 Aug 13;388(10045):717–27. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26948435?dopt=Abstract
Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis. Neuroepidemiology [Internet]. 2011;36(2):123–33. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703046/
Palma D, Dm P, An C, Dl C, Plasmapheresis T, Barré G. Neurological Case Reports Plasmapheresis and Guillain-Barré Syndrome: Desperate Therapy for Desperate Patient? A Case Report OPEN ACCESS Citation. 2022 [cited 2025 May 8];5. Available from: https://www.remedypublications.com/open-access/plasmapheresis-and-guillainndashbarreacute-syndrome-desperate-therapy-for-8573.pdf
Osterman PO, Fagius J, Safwenberg J, Danersund A, Wallin BG, Nordesjo LO . Treatment of the Guillain-Barre Syndrome by Plasmapheresis. Archives of Neurology. 1982 Mar 1;39(3):148–54.
Zito A, Alfonsi E, Franciotta D, Todisco M, Gastaldi M, Cotta Ramusino M, et al. COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature. Frontiers in Neurology. 2020 Aug 21;11.
Nilse Querino Santos, Cláudia A, Antonio Alberto Lopes, Costa G, Aroldo Bacellar. Guillain-Barré syndrome in the course of dengue: case report. 2004 Mar 1;62(1):144–6.
Hartung HP, Toyka KV, Pollard JD, Harvey GK. Immunopathogenesis and treatment of the guillain-barr?syndrome?part I. Muscle & Nerve. 1995 Feb;18(2):137–53.
Meena A, Murthy JMK, Khadilkar S. Treatment guidelines for Guillain-Barré Syndrome. Annals of Indian Academy of Neurology [Internet]. 2011;14(5):73.
Availablefrom:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152164/
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
